Gibtulio 25mg Tablet contains Empagliflozin 25mg, an SGLT2 inhibitor used primarily for the management of Type 2 Diabetes Mellitus. It helps lower blood glucose by reducing the reabsorption of glucose in the kidneys, allowing excess glucose to be eliminated through urine. Gibtulio 25mg may also be prescribed for eligible adults with heart failure or chronic kidney disease, where empagliflozin can help reduce the risk of hospitalization and support cardiovascular and kidney health. It is generally taken once daily, with or without food, as directed by a healthcare professional. Common side effects may include increased urination, thirst, urinary tract infections, and genital yeast infections. Adequate hydration is important during treatment. This is a prescription medicine and should be used only under medical supervision, particularly in people with kidney problems or those taking other medicines that can lower blood sugar. Composition: Empagliflozin 25mg Therapeutic Class: Antidiabetic / SGLT2 Inhibitor Dosage Form: Tablet Prescription: Required